Nicole Walker, MD
Surgical Oncology · New Orleans, LANPI 1659520898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,539, 9.7 times the $159 reported in 2022.
Across 166 payments — averaging $20.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$314
- Incyte Corporation$281
- Takeda Pharmaceuticals U.S.A., Inc.$234
- Bayer$215
- Merck$201
- AstraZeneca$189
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,397100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,397 in reported general payments places this provider in the 60th percentile of 26 surgical oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 36 | $114 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in New Orleans
- Nathan BoltonNew Orleans$6K
- Shawn McKinneyNew Orleans$4K
- David PointerNew Orleans$4K
- Amy RivereNew Orleans$4K
- Omeed MoavenNew Orleans$3K
- Mohamed ShamaNew Orleans$2K
- Saad Al AwwadNew Orleans$2K
- Russell BrownNew Orleans$2K
- Jane WeyNew Orleans$1K
- George FuhrmanNew Orleans$675
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.